Concepedia

Katie E. Archer

KE

7

Publications

302

Citations

7

H-Index

1995

Active since

Affiliations

ImmunoGen (United States)(Current)

Katie E. Archer is an author at ImmunoGen (United States) specializing in tumor biology, biomolecular engineering, and drug discovery.

Top concepts

Publications per year

1995–2019

7

Publications

7

A New Class of Antibody–Drug Conjugates with Potent DNA Alkylating Activity

Michael L. Miller, Nathan Fishkin, Wěi Li et al. · Molecular Cancer Therapeutics · 2016 · 100 citations

, , +16

A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody–Drug Conjugates (ADCs)

Michael L. Miller, Manami Shizuka, Alan Wilhelm et al. · Molecular Cancer Therapeutics · 2018 · 53 citations · Full text

Optimizing Lysosomal Activation of Antibody–Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers

Paulin Salomon, Emily E. Reid, Katie E. Archer et al. · Molecular Pharmaceutics · 2019 · 48 citations · Full text

Further analysis of the mechanisms underlying the tracheal relaxant action of SCA40

Susan Cook, Katie E. Archer, A. Martin et al. · British Journal of Pharmacology · 1995 · 38 citations · Full text

Site-Specific Conjugation of the Indolinobenzodiazepine DGN549 to Antibodies Affords Antibody–Drug Conjugates with an Improved Therapeutic Index as Compared with Lysine Conjugation

Chen Bai, Emily E. Reid, Alan Wilhelm et al. · Bioconjugate Chemistry · 2019 · 30 citations · Full text

Rows per page

1–5 of 7